Wan Xinyue, Zhang Wenjie, Dai Lingyan, Chen Liang
School of Medicine, Chongqing University, Chongqing 400030, China.
Department of Bone and Soft Tissue Oncology, Chongqing University Cancer Hospital, Chongqing University School of Medicine, Chongqing 400030, China.
Curr Issues Mol Biol. 2024 Aug 23;46(9):9269-9285. doi: 10.3390/cimb46090548.
Extracellular vesicles (EVs) are nanoscale particles with a lipid bilayer membrane structure secreted by various cell types. Nearly all human cells secrete EVs, primarily mediating intercellular communication. In recent years, scientists have discovered that EVs can carry multiple biological cargos, such as DNA, non-coding RNAs (ncRNAs), proteins, cytokines, and lipids, and mediate intercellular signal transduction. Bone is a connective tissue with a nerve supply and high vascularization. The repair process after injury is highly complex, involving interactions among multiple cell types and biological signaling pathways. Bone regeneration consists of a series of coordinated osteoconductive and osteoinductive biological processes. As mediators of intercellular communication, EVs can promote bone regeneration by regulating osteoblast-mediated bone formation, osteoclast-mediated bone resorption, and other pathways. This review summarizes the biogenesis of EVs and the mechanisms by which EV-mediated intercellular communication promotes bone regeneration. Additionally, we focus on the research progress of EVs in various diseases related to bone regeneration. Finally, based on the above research, we explore the clinical applications of engineered EVs in the diagnosis and treatment of bone regeneration-related diseases.
细胞外囊泡(EVs)是由各种细胞类型分泌的具有脂质双分子层膜结构的纳米级颗粒。几乎所有人类细胞都会分泌EVs,主要介导细胞间通讯。近年来,科学家发现EVs可以携带多种生物物质,如DNA、非编码RNA(ncRNAs)、蛋白质、细胞因子和脂质,并介导细胞间信号转导。骨是一种具有神经供应和高血管化的结缔组织。损伤后的修复过程高度复杂,涉及多种细胞类型和生物信号通路之间的相互作用。骨再生由一系列协调的骨传导和骨诱导生物学过程组成。作为细胞间通讯的介质,EVs可以通过调节成骨细胞介导的骨形成、破骨细胞介导的骨吸收和其他途径来促进骨再生。本文综述了EVs的生物发生以及EV介导的细胞间通讯促进骨再生的机制。此外,我们关注EVs在各种与骨再生相关疾病中的研究进展。最后,基于上述研究,我们探讨工程化EVs在骨再生相关疾病诊断和治疗中的临床应用。
Curr Issues Mol Biol. 2024-8-23
Front Cell Dev Biol. 2022-5-11
Acta Biomater. 2020-6
J Bone Miner Res. 2017-12-11
Mater Today Bio. 2022-12-21
J Biomed Mater Res A. 2024-2
Bone Res. 2024-1-23
Cell Commun Signal. 2023-9-25
Front Endocrinol (Lausanne). 2023
Stem Cell Res Ther. 2023-3-29
Nat Rev Mol Cell Biol. 2023-7
J Control Release. 2023-3